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Abstract 
S. epidermidis infections on medically implanted devices are a common problem in modern 
medicine due to the abundance of the bacteria. Once inside the body, S. epidermidis gather in 
communities called biofilms and can become extremely hard to eradicate, causing the patient 
serious complications. We simulate the complex S. epidermidis-Neutrophils interactions in order 
to determine the optimum conditions for the immune system to be able to contain the infection 
and avoid implant rejection. Our cellular automata model can also be used as a tool for 
determining the optimal amount of antibiotics for combating biofilm formation on medical 
implants. 
Keywords:     Medical implants, Neutrophils, S. epidermidis, biofilms, Cellular automata  
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1.  Introduction 
Medically implanted devices are becoming increasingly important in medical practice, Xue et al. 
(2007). Due to the abundance of skin-colonizing bacteria, infectious reactions on such implants 
constitute a problem for modern medicine, Otto (2009). The most common member of the group 
of coagulase-negative staphylococci is Staphyloccocus epidermidis, Vuong and Otto (2002), 
which is a bacterial colonizer of the skin and mucous membranes of humans and other mammals, 
Otto (2009). It has been characterized as the main pathogen involved in nosocomial bloodstream 
infections, cardiovascular infections, and infections of the eye, ear, nose and throat, Vuong and 
Otto (2002). Being a common colonizer of human skin and one of the most often isolated 
bacterial pathogens in hospitals it is almost impossible to prevent S. epidermidis from entering 
the body while inserting a medical implant, Vuong and Otto (2002) and Otto (2009). Once in the 
body, S. epidermidis can lead to a wide variety of complications including inflammation, 
thrombosis, infections and fibrosis, Xue et al. (2007). These complications have a direct effect on 
the stability of the implanted device because they trigger immune responses, including a rapid 
accumulation of phagocytic cells, Xue et al. (2007).  
If the immune system is not able to eradicate S. epidermidis during the first hours after it has 
entered the body then biofilm formation is likely to commence. A biofilm consists of bacterial 
cells immobilized in a substratum which is frequently embedded in an organic polymer matrix of 
microbial origin. Biofilms appear in many different forms, including layers, clumps ridges, and 
even more complex micro-colonies that are arranged into stalks or mushroom-like formations, 
Costerton (1999) and Eberhard et al. (2005). Once protected by the biofilm, bacteria become 
difficult for the immune system to eradicate, Gunter et al. (2009), and studies suggest that 
biofilms are present on the surface of the implant as early as 16 hours after implantation, Gunter 
et al. (2009). However young biofilms are more vulnerable to phagocytic cells than mature ones 
which have been growing for more than 48 hours, Gunter et al. (2009). In addition, most 
antibiotics are only effective against the fast growing bacteria which reside in the outer layers of 
the biofilm, while the slow growing bacteria deep inside of the biofilm formation tend to be 
spared and to persist in the body, Eberhard et al. (2005).  
Therefore, it is critical that the immune system destroys the majority of the bacteria before a 
biofilm begins to form. Recent studies suggest that biofilm formation by S. epidermidis is 
regulated by a chemical communication between the bacteria called the agr system, Kong et al. 
(2006). When bacterial communities reach a certain size they are ready to gather into a biofilm, 
so they start releasing a specific chemical that will give the signal to start the attachment process. 
By disrupting the agr system these chemicals are never released then the biofilm will never form, 
which allows the immune system to kill the bacteria and contain the infection.  
Of all the types of phagocytic cells, the most important to the immune system's defence against 
S. epidermidis are the white blood cells Neutrophils. In order to attack the S. epidermidis 
growing on medical implants, Neutrophils cells adhere to the surface of the device and move 
towards the bacterial formations, Xue et al. (2007). The strength of Neutrophils adhesion to the 
medical implant depends on the type of protein present on the surface of the implant. Fibrinogen 
and Albumin are two of the most commonly used protein coatings on medically implanted 
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devices. Fibrinogen facilitates a strong attachment between Neutrophils and the implant since it 
is readily recognized as a malign substance by the immune system. However, Fibrinogen also 
works as a distraction to the Neutrophils because the phagocytes place themselves in one spot 
attacking the Fibrinogen covered implant and move very slowly towards the bacteria, Tang and 
Eaton (1993) and Kuntz and Saltzman (1997). In contrast, Albumin is not recognized by the 
phagocytes as a malign substance and hence the Neutrophils cells can move freely around the 
implant.  
Another important distinction between Albumin and Fibrinogen is the amount of Neutrophils 
each protein coating attracts. Experimental studies suggest that two groups of chemokines 
macrophage inflammatory protein (MIP) and monocyte chemoattactant protein (MCP) appear to 
play a major role in phagocyte-implant interactions, Xue et al. (2007). By releasing chemokines, 
the Neutrophils cells present on the surface of the implant are able to attract more Neutrophils to 
the site. These chemotactic interactions create waves of incoming phagocytic cells, which aid in 
the fight against the bacterial infection. While Fibrogen covered implants are interpreted as a 
threat to the body and many phagocytes are attracted to them, the Albumin coated implant is not 
perceived as a threat and thus fewer phagocytes are present to fight the infection. 
In this paper we examine a variety of mixtures of Fibrinogen and Albumin implant coatings in 
order to maximize the effectiveness of the immune system response. Finding the optimum 
amounts of each of these two proteins will help the immune system destroy most of the bacteria 
before they start to form biofilm communities. This will reduce the number of rejections of 
medically implanted devices and drastically improve the ability of the body’s immune system to 
combat bacterial infections. Our simulations can also be used to help determine the appropriate 
amount of antibiotics to use over the implant area so that an S. epidermidis infection can be 
successfully controlled as well as to predict what will happen if biofilm formation is avoided.  
 
2.  Cellular Automata Models 
Cellular automata models are dynamical systems in which space and time are discrete, Eberhard 
et al. (2005).  A cellular automaton consists of a regular grid, each of which can be in one of a 
finite number of possible states updated synchronously in discrete time steps according to local, 
identical rules, Mallet and de Pillis (2006). In this paper, we employ a cellular automata 
modeling approach to simulate interactions between Neutrophils and S. epidermidis subject to a 
variety of coatings of Albumin and Fibrinogen mixtures on a medically implanted device. A set 
of rules for the movement of the cells and the growth of the bacteria is given for the two different 
types of protein coatings. The amounts of Albumin and Fibrinogen in the mixture are allowed to 
be varied, since they have different effects on the speed of the Neutrophils and their ability to 
control a bacterial infection. 
We consider a biased motility model, in which Neutrophil cells move with greater probability 
towards larger bacterial concentrations. The model is divided into three parts. The first part 
simulates the complex S. epidermidis-Neutrophils interactions between 4 and 20 hours after the 
implant is introduced into the body. We consider the reproduction of bacteria at the early stage of 
a bacterial community formation which triggers the immune response. We also incorporate a 
series of chemotaxing waves of Neutrophils cells in our model. The second part of the model 
simulates the system dynamics after the S. epidermidis have started forming a biofilm which 
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takes place between the 20 and the 52 hours. During this part of the simulation, bacteria 
experience an increase in the reproduction rate while the immune system response gradually 
decreases effectiveness as the biofilms become stronger. The last part of the model, after the 52 
hours, the immune system can no longer fight S.epidermidis since they are all gather in fully 
formed strong biofilms.  
The novelty of this mathematical approach is the implementation of the cellular automata on 
different scales. The two-scale discrete CA model includes one scale for the Neutrophils and 
another scale for the bacteria, taking into consideration the much larger size of the white blood 
cells. 
 
3.  Numerical Implementation 
Our biased motility cellular automata model is implemented on an SxS grid. A square in the grid 
is occupied by bacteria with a variable density while a Neutrophil cell occupies a cxc square.  
Each square in the grid is in one of the following four states: 
 Empty 
 Covered with S. epidermidis 
 Covered with a Neutrophil cell and S. epidermidis 
 Covered with a Neutrophil cell but without any bacteria present 
 
Each numerical simulation consists of a series of iterative steps. We initialize the model with two 
SxS matrices. Every entry in each matrix represents a square in the grid described above. On the 
first matrix we randomly select m blocks of cxc numbered squares, each block representing a 
single Neutrophil cell. Each cell has the ability to move in 8 different directions (Figure 1). 
Direction i is chosen with probability Pi, i = 1 ,..., 8 where the value of Pi depends on the 
concentration of bacteria in each direction. In the second matrix, b units of S. epidermidis are 
placed randomly, with no limit on the number of bacteria that can reside in a single grid square.  
Each block of cxc squares in the matrix that represents the Neutrophil cells is uniquely 
numbered. Every time step we check the area under each cell for S. epidermidis bacteria. 
Consequently, one of the following two cases holds: 
 There are some bacteria under the area covered by the Neutrophil. In this case, the 
Neutrophil doesn't move and consumes one unit of bacteria each time step until there 
is no more bacteria under the area covered by the Neutrophil.  
 There are no bacteria under the area covered by the Neutrophil. In this case, the cell 
moves to an available, free from other Neutrophil cells, neighboring space i, i=1,…,8,  
(Figure 1) with a probability Pi. 
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Figure 1. Directions i=1,…,8 for movement of the Neutrophil cells. 
The direction i of cell movement is determined randomly according to specific probabilities 
assigned to each direction. The Neutrophil cells move toward a higher concentration of bacteria 
with a greater probability Pi. To compute Pi, we consider a 3x3 grid and place the Neutrophil cell 
on the center square in the grid. Then we calculate Pi  according to the formula Pi = Ai/B, i = 
1,...,8, where B is the total amount of bacteria on each of the 8 squares surrounding the cell and 
Ai is the amount of S. epidermidis on each of the surrounding positions. 
To take into consideration the chemotaxis interactions between the Neurophil cells, we add G 
additional cells to the system every dx units of time, where dx is a constant, and G is a function 
of the protein mixture, the amount of bacteria currently present and, the amount of phagocytes in 
the model at that time. The new cells are placed randomly on available spaces of the implant 
ensuring that no two cells overlap on the implant. The protein coating is a mixture of Albumin 
and Fibrinogen. For convenience, we will use the variable A to quantify the percentages of 
Albumin in the protein coating mixture. A is a number between 0 and 1 which indicates the 
fraction of Albumin in the protein coating mixture while 1-A represents the fractional amount of 
Fibrinogen in the protein coating mixture.  
 
4.  Numerical Simulations 
In order to examine the effect of Neutrophils ability to identify bacteria on the progression of the 
bacterial infection, we run a set of biased motility simulations. The amounts of Fibrinogen and 
Albumin are varied in the implant’s coating mixture in order to determine the optimal amounts of 
each protein that facilitate the best immune system response. We use Matlab® to implement our 
biased motility cellular automata model. The time unit used for the simulations is Δt=20 
seconds, which is the same as the approximate time that it takes for a Neutrophil cell to ingest a 
single S. epidermidis bacterium. In our numerical simulations we model the first 76 hours after 
the implant is introduced to the body. After the initial 20 hours, S. epidermidis bacteria start 
forming a biofilm and the immune system gradually becomes less effective in fighting the 
bacterial infection. After 52 hours, the immune system can no longer fight the infection.  
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The specific functions and parameters that are used in the simulations are listed below. The time 
at which new Neutrophils are incorporated into the simulation, dx, is given by  
,180 tdx   
this represents a one-hour interval and is consistent with the available experimental data that we 
are basing the model on. When levels of Albumin decrease more Neutrophils are recruited which 
means chemotaxis becomes stronger which means that more Neutrophils are incorporated into 





















to represent the amount of new Neutrophil cells that are incorporated into the system every hour. 
Here, A represents the fraction of Albumin in the protein mixture; b is the current amount of 
bacteria, n is the number of Neutrophils currently on the simulation and β is a normalizing factor. 
For the experiments we are running β=9072 since this represents the average initial bacteria on 
the experimental implant, Tang (2010). 
The more Albumin in the mixture the fewer Neutrophils cells are recruited into the implant. As 
bacteria accumulate on the surface of the implant, more Neutrophils are recruited due to 
chemotaxis which increases the ability of the immune system to fight the infection. According to 
experimental data, approximately 40% more Neutrophils are found when Fibrinogen is the only 
protein used to cover the implant as opposed to when only Albumin coating is used, Tang and 












where the function m depends only on the amounts of Albumin in the protein mixture and the 
initial amounts of bacterium since there are no Neutrophils on the surface of the implant at this 
point. There will be more cells recruited when less Albumins is present in the mixture.  
As said before, it takes Neutrophils more time to move on a Fibrinogen surface than on an 
Albumin surface. To account for this we use the function Ts which represents the time that it 
takes each Neutrophils cell to move one unit in space (a square in the grid of the model) 
 .)( )1(4 AS efloorAT   
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Figure 2.  Snapshots of the initial (left) and final (right) state of the system in a 20-hour 
simulation 
Other parameters used in the simulations include c, the size of the cxc square on the grid that a 
single Neutrophil cell occupies, and S, the size of the SxS grid used in the cellular automata 
models. We use c=12 since the ratio between the radius of a Neutrophil cell and an S. 
epidermidis bacteria is approximately 1:12, and S=120 which represents a grid of size 
approximately .01% of the area of a biomedical implant used in practice. We also consider the 
generation time of the bacteria inside a biofilm to be 200 minutes, Konig et al. (2001), while the 
generation time of free bacteria under stress to be 600 minutes, Tang (2010). 
 
Figure 3. Percentage of effective simulations using a biased motility model 
We run the simulation 10,000 times for 76 hours, retrieving the amount of bacteria left in each 
simulation after 20 (Figure 2), 52 and 76  hours. An effective simulation is defined as a 
simulation in which at most 1% of the implant area is covered with bacteria after 76 hours. The 
graph below shows the percentage of effective simulations for all values of Albumin between 0% 
and 100% in 10% increments (% of Fibrinogen=100 - % of Albumin) after 20, 52 and 76 hours.  
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Figure 3 shows the results of the simulations using our biased motility model, which yielded 
results similar to published experimental data by Tang and Eaton (1995).  
In order to improve the results for all Albumin and Fibrinogen percentages two strategies could 
be used: (1) medical devices can be pre-coated with antibiotics before implantation; or (2) 
biofilm formation can be blocked, Kong et al. (2006). The model was modified as follows to 
include both approaches: 
 To include the effect of antibiotics in our original model, every certain amount of time 
some percentage of the bacteria is eliminated at random from the implant. The amount of 
time and percentages can be modified to describe the effect of different types of 
antibiotics. The effects of a sample antibiotic on the different mixtures after a series of 
76-hour simulations are shown on the graphs below (Figure 4, left). 
 Bioflim formation can be avoided by disrupting the agr system to prevent the attachment 
of bacterial cells. Our original cellular automata model was modified to neglect biofilm 
formation by treating the 20-to-76-hour parts similarly to the 4-to-20-hour part of the 
model. Bacteria are treated as free bacteria, and Neutrophils are able to kill bacteria at the 
same speed during the entire 76-hour simulation. The results are shown on the graphs 
below (Figure 4, right) where the effect of disrupting the agr system can be easily 
observed. 
 
Figure 4. The effects of different doses of antibiotics (left) and the absence of biofilm 
formation (right) on bacterial infections 
 
5.  Discussion and Conclusions 
Using a biased motility cellular automata model we have numerically investigated the 
interactions between S. epidermidis and Neutrophils on the surface of a medically implanted 
device with protein-coating mixtures of Ablumin and Fibrinogen. By using our model, we found 
an array of different protein-coating mixtures that maximize the immune response while 
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minimizing the rejection caused by infection or inflammation. We also found the different 
protein-coating mixtures that prevent biofilms from forming on the surface of the implant 
altogether.  
Using this CA model we were able to obtain a range of protein-coating mixtures which 
maximizes the percentage of effective simulations. Over 99.7% of the experiments with mixtures 
between 30% Albumin (i.e., 70% Fibrinogen) and 70% Albumin (i.e., 30% Fibrinogen) were 
successful in eradicating the bacteria. Inside that range, mixtures of 40% Albumin and 60% 
Albumin were the most efficient (with 99.9% effective simulations).  
The model was also used to determine the effects of pre-coating implants with antibiotics before 
insertion. We ran the simulations for different doses of antibiotics to determine how many doses 
are needed to prevent biofilm formation. We were able to conclude that with three doses of 
antibiotics all protein coating mixtures yield effectiveness above 97.0%. For different antibiotics 
the simulation can be rescaled to represent accurate amounts of that specific antibiotic needed to 
successfully avoid biofilm formation under any protein-coating mixture.  
Finally the biased motility model was used to determine what will happen if biofilm formation 
can be prevented completely. The simulation showed that in this case all protein coating 
mixtures will control the infection over 97% of the time. If we could keep S. epidermidis from 
gathering into a biofilm, then very low percentages of Fibrinogen can be used on the protein 
coating mixture while having 99.9% effectiveness. This could mean greater efficiency in spite of 
low Neutrophils recruitment, which will lead to less inflammation.  
In this work, we also implemented an unbiased (random) motility model, in which Neutrophil 
cells move at random on the surface of the implant.  The results from the random motility model 
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